ID   GLRA3_RAT               Reviewed;         464 AA.
AC   P24524;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 1.
DT   02-OCT-2024, entry version 160.
DE   RecName: Full=Glycine receptor subunit alpha-3;
DE   Flags: Precursor;
GN   Name=Glra3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2176214; DOI=10.1016/s0021-9258(18)45707-9;
RA   Kuhse J., Schmieden V., Betz H.;
RT   "Identification and functional expression of a novel ligand binding subunit
RT   of the inhibitory glycine receptor.";
RL   J. Biol. Chem. 265:22317-22320(1990).
RN   [2]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, PHOSPHORYLATION AT
RP   SER-379, AND MUTAGENESIS OF SER-379.
RX   PubMed=15131310; DOI=10.1126/science.1094925;
RA   Harvey R.J., Depner U.B., Waessle H., Ahmadi S., Heindl C., Reinold H.,
RA   Smart T.G., Harvey K., Schuetz B., Abo-Salem O.M., Zimmer A., Poisbeau P.,
RA   Welzl H., Wolfer D.P., Betz H., Zeilhofer H.U., Mueller U.;
RT   "GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory
RT   pain sensitization.";
RL   Science 304:884-887(2004).
RN   [3]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19723286; DOI=10.1111/j.1460-9568.2009.06903.x;
RA   Eichler S.A., Foerstera B., Smolinsky B., Juettner R., Lehmann T.N.,
RA   Faehling M., Schwarz G., Legendre P., Meier J.C.;
RT   "Splice-specific roles of glycine receptor alpha3 in the hippocampus.";
RL   Eur. J. Neurosci. 30:1077-1091(2009).
RN   [4]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, ACTIVITY REGULATION,
RP   PHOSPHORYLATION AT SER-379, AND MUTAGENESIS OF SER-379.
RX   PubMed=23834509; DOI=10.1021/cn400097j;
RA   Han L., Talwar S., Wang Q., Shan Q., Lynch J.W.;
RT   "Phosphorylation of alpha3 glycine receptors induces a conformational
RT   change in the glycine-binding site.";
RL   ACS Chem. Neurosci. 4:1361-1370(2013).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF PRO-218.
RX   PubMed=23895467; DOI=10.1111/acer.12192;
RA   McCracken L.M., Trudell J.R., McCracken M.L., Harris R.A.;
RT   "Zinc-dependent modulation of alpha2- and alpha3-glycine receptor subunits
RT   by ethanol.";
RL   Alcohol. Clin. Exp. Res. 37:2002-2010(2013).
RN   [6]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=23613537; DOI=10.1113/jphysiol.2013.252189;
RA   Marabelli A., Moroni M., Lape R., Sivilotti L.G.;
RT   "The kinetic properties of the alpha3 rat glycine receptor make it suitable
RT   for mediating fast synaptic inhibition.";
RL   J. Physiol. (Lond.) 591:3289-3308(2013).
RN   [7]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=25445488; DOI=10.1016/j.neuropharm.2014.10.026;
RA   Zhang Y., Dixon C.L., Keramidas A., Lynch J.W.;
RT   "Functional reconstitution of glycinergic synapses incorporating defined
RT   glycine receptor subunit combinations.";
RL   Neuropharmacology 89:391-397(2015).
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels. Channel
CC       opening is triggered by extracellular glycine (PubMed:15131310,
CC       PubMed:23613537, PubMed:23834509, PubMed:23895467). Channel
CC       characteristics depend on the subunit composition; heteropentameric
CC       channels display faster channel closure (PubMed:25445488). Plays an
CC       important role in the down-regulation of neuronal excitability (By
CC       similarity). Contributes to the generation of inhibitory postsynaptic
CC       currents (PubMed:25445488). Contributes to increased pain perception in
CC       response to increased prostaglandin E2 levels (By similarity). Plays a
CC       role in cellular responses to ethanol (PubMed:23895467).
CC       {ECO:0000250|UniProtKB:Q91XP5, ECO:0000269|PubMed:15131310,
CC       ECO:0000269|PubMed:23834509, ECO:0000269|PubMed:23895467,
CC       ECO:0000269|PubMed:25445488}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823,
CC         ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:15131310,
CC         ECO:0000269|PubMed:23613537, ECO:0000269|PubMed:23834509,
CC         ECO:0000269|PubMed:23895467, ECO:0000269|PubMed:25445488};
CC   -!- ACTIVITY REGULATION: Low levels of Zn(2+) ions (1 uM) increase glycine
CC       sensitivity and decrease the glycine concentration required for half-
CC       maximal channel activity (PubMed:23895467). Channel activity is
CC       strongly enhanced by ethanol (PubMed:23895467). Inhibited by picrotoxin
CC       (PubMed:23834509). Inhibited by prostaglandin E2, probably via PKA-
CC       mediated phosphorylation at Ser-379 (PubMed:15131310).
CC       {ECO:0000269|PubMed:15131310, ECO:0000269|PubMed:23834509,
CC       ECO:0000269|PubMed:23895467}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=A concentration of about 900 uM glycine results in half-maximal
CC         channel conductance in the absence of Zn(2+). In the presence of 1 uM
CC         Zn(2+), 400uM glycine results in half-maximal channel conductance.
CC         {ECO:0000269|PubMed:23895467};
CC   -!- SUBUNIT: Homopentamer (in vitro) (By similarity). Heteropentamer
CC       composed of GLRA3 and GLRB. Both homopentamers and heteropentamers form
CC       functional ion channels, but their characteristics are subtly different
CC       (PubMed:25445488). {ECO:0000250, ECO:0000269|PubMed:25445488}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000305|PubMed:19723286}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O75311}. Perikaryon
CC       {ECO:0000269|PubMed:19723286}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:19723286}. Synapse {ECO:0000269|PubMed:19723286}.
CC       Cell membrane {ECO:0000269|PubMed:15131310,
CC       ECO:0000269|PubMed:19723286, ECO:0000269|PubMed:23613537,
CC       ECO:0000269|PubMed:23834509, ECO:0000269|PubMed:23895467,
CC       ECO:0000269|PubMed:25445488}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O75311}. Note=Partially colocalizes with GPHN
CC       that is known to mediate receptor clustering at postsynaptic membranes.
CC       {ECO:0000269|PubMed:19723286}.
CC   -!- DOMAIN: The N-terminal domain carries structural determinants essential
CC       for agonist and antagonist binding. The channel pore is formed by
CC       pentameric assembly of the second transmembrane domain from all five
CC       subunits. The cytoplasmic loop is an important determinant of channel
CC       inactivation kinetics. {ECO:0000250|UniProtKB:O75311}.
CC   -!- PTM: Phosphorylated by PKA; this causes down-regulation of channel
CC       activity (Probable). {ECO:0000305|PubMed:15131310,
CC       ECO:0000305|PubMed:23834509}.
CC   -!- MISCELLANEOUS: The alpha subunit binds strychnine.
CC       {ECO:0000250|UniProtKB:O75311}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Glycine receptor (TC 1.A.9.3) subfamily. GLRA3 sub-subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M55250; AAA63492.1; -; mRNA.
DR   PIR; A23682; A23682.
DR   AlphaFoldDB; P24524; -.
DR   SMR; P24524; -.
DR   STRING; 10116.ENSRNOP00000069714; -.
DR   ChEMBL; CHEMBL3392921; -.
DR   GlyCosmos; P24524; 1 site, No reported glycans.
DR   GlyGen; P24524; 1 site.
DR   iPTMnet; P24524; -.
DR   PhosphoSitePlus; P24524; -.
DR   PaxDb; 10116-ENSRNOP00000067536; -.
DR   ABCD; P24524; 1 sequenced antibody.
DR   AGR; RGD:621229; -.
DR   RGD; 621229; Glra3.
DR   eggNOG; KOG3644; Eukaryota.
DR   InParanoid; P24524; -.
DR   Reactome; R-RNO-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:P24524; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0016935; C:glycine-gated chloride channel complex; ISS:UniProtKB.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:RGD.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:1902495; C:transmembrane transporter complex; IBA:GO_Central.
DR   GO; GO:0016934; F:extracellularly glycine-gated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0016594; F:glycine binding; IEA:InterPro.
DR   GO; GO:0022852; F:glycine-gated chloride ion channel activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IDA:UniProtKB.
DR   GO; GO:0071361; P:cellular response to ethanol; IDA:UniProtKB.
DR   GO; GO:0071294; P:cellular response to zinc ion; IDA:UniProtKB.
DR   GO; GO:1902476; P:chloride transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; ISO:RGD.
DR   CDD; cd19009; LGIC_ECD_GlyR_alpha; 1.
DR   CDD; cd19060; LGIC_TM_GlyR_alpha; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008127; Glycine_rcpt_A.
DR   InterPro; IPR008130; Glycine_rcpt_A3.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF455; GLYCINE RECEPTOR SUBUNIT ALPHA-3; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01673; GLYRALPHA.
DR   PRINTS; PR01676; GLYRALPHA3.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Chloride; Chloride channel; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Metal-binding; Phosphoprotein; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Zinc.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000255"
FT   CHAIN           34..464
FT                   /note="Glycine receptor subunit alpha-3"
FT                   /id="PRO_0000000421"
FT   TOPO_DOM        34..255
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   TRANSMEM        256..277
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   TOPO_DOM        278..282
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   TRANSMEM        283..303
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   TOPO_DOM        304..314
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   TRANSMEM        315..335
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   TOPO_DOM        336..430
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   TRANSMEM        431..451
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   TOPO_DOM        452..464
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   BINDING         225
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   BINDING         227
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   BINDING         235..240
FT                   /ligand="strychnine"
FT                   /ligand_id="ChEBI:CHEBI:90700"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   BINDING         248
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   SITE            294
FT                   /note="Important for obstruction of the ion pore in the
FT                   closed conformation"
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   MOD_RES         370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91XP5"
FT   MOD_RES         379
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000305|PubMed:15131310,
FT                   ECO:0000305|PubMed:23834509"
FT   CARBOHYD        71
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        171..185
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   DISULFID        231..242
FT                   /evidence="ECO:0000250|UniProtKB:O75311"
FT   MUTAGEN         218
FT                   /note="P->L: Strongly enhances glycine sensitivity so that
FT                   the channel starts to be activated at 0.001 mM glycine."
FT                   /evidence="ECO:0000269|PubMed:23895467"
FT   MUTAGEN         379
FT                   /note="S->A: Loss of a predicted PKA phosphorylation site.
FT                   Nearly abolishes down-regulation of inhibitory postsynaptic
FT                   currents by prostaglandin E2."
FT                   /evidence="ECO:0000269|PubMed:15131310"
FT   MUTAGEN         379
FT                   /note="S->E: Phosphomimetic mutant that triggers a local
FT                   conformation change."
FT                   /evidence="ECO:0000269|PubMed:23834509"
FT   MUTAGEN         379
FT                   /note="S->G: Loss of a predicted PKA phosphorylation site.
FT                   Abolishes the conformation change observed after treatment
FT                   with forskolin."
FT                   /evidence="ECO:0000269|PubMed:23834509"
SQ   SEQUENCE   464 AA;  53672 MW;  5A429F4C6F16E40D CRC64;
     MAHVRHFRTL LSGFYFWEAA LLLSLVATKE TNSARSRSAP MSPSDFLDKL MGRTSGYDAR
     IRPNFKGPPV NVTCNIFINS FGSIAETTMD YRVNIFLRQK WNDPRLAYSE YPDDSLDLDP
     SMLDSIWKPD LFFANEKGAN FHEVTTDNKL LRIFKNGNVL YSIRLTLTLS CPMDLKNFPM
     DVQTCIMQLE SFGYTMNDLI FEWQDEAPVQ VAEGLTLPQF LLKEEKDLRY CTKHYNTGKF
     TCIEVRFHLE RQMGYYLIQM YIPSLLIVIL SWVSFWINMD AAPARVALGI TTVLTMTTQS
     SGSRASLPKV SYVKAIDIWM AVCLLFVFSA LLEYAAVNFV SRQHKELLRF RRKRKNKTEA
     FALEKFYRFS DTDDEVRESR LSFTAYGMGP CLQAKDGVVP KGPNHAVQVM PKSADEMRKV
     FIDRAKKIDT ISRACFPLAF LIFNIFYWVI YKILRHEDIH HQQD
//
